BTMD
biote Corp
1.20$
-2.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.3% | +2.4% | +5.1% | +4.5% | -3.0% | -1.7% | -0.3% | -1.9% | -3.2% | -3.2% | -1.6% | – | |
| – | -1.1% | -3.9% | +13.4% | -0.5% | -5.7% | -11.8% | +10.0% | -2.4% | +9.6% | -5.7% | +119.1% | – | |
| – | +1.0% | +5.2% | +1.7% | +6.8% | -1.9% | +2.4% | -3.8% | -1.6% | -8.3% | -2.0% | -56.0% | – | |
| – | +105.3% | -52.9% | +20.2% | -13.1% | +36.4% | -18.5% | -9.2% | +8.0% | -5.4% | +12.3% | +16.7% | – | |
| – | +10.1% | -12.5% | +20.3% | -12.9% | +36.4% | -18.5% | -9.2% | +8.0% | -5.4% | +12.3% | -38.4% | – | |
| – | -27.5% | +89.3% | -39.2% | +92.2% | -77.3% | +250.2% | +11.1% | -23.2% | -17.4% | -53.6% | -210.8% | – | |
| – | +0.8% | +7.7% | +55.2% | +37.4% | -9.0% | -9.8% | -1.8% | -4.2% | -9.6% | -20.2% | +10.7% | – | |
| – | -60.3% | -135.6% | – | – | -107.7% | – | -65.2% | +39.1% | -33.7% | -40.4% | -313.7% | – | |
| – | -170.8% | – | -97.0% | +4,280.8% | -247.1% | – | +33.0% | -135.6% | – | -77.8% | -55.3% | – | |
| – | +2.7% | -153.8% | – | – | -65.4% | +270.5% | -76.8% | +157.1% | -76.1% | +16.5% | -388.2% | – | |
| – | -9.8% | -109.4% | – | +131.8% | -84.5% | +575.7% | -53.6% | +23.4% | -25.6% | -30.3% | -163.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.